Mirum Pharmaceuticals, Inc. announces preliminary unaudited revenues for Q4 and fiscal year 2022 and the departure of Chief Financial Officer Ian Clements.
AI Assistant
MIRUM PHARMACEUTICALS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.